NovoCure Ltd (NVCR)
11.83
-0.26
(-2.15%)
USD |
NASDAQ |
Apr 22, 16:00
12.40
+0.57
(+4.82%)
After-Hours: 20:00
NovoCure Cash from Operations (TTM): -73.34M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -73.34M |
September 30, 2023 | -62.48M |
June 30, 2023 | -20.75M |
March 31, 2023 | 17.75M |
December 31, 2022 | 30.79M |
September 30, 2022 | 48.90M |
June 30, 2022 | 50.88M |
March 31, 2022 | 61.29M |
December 31, 2021 | 82.76M |
September 30, 2021 | 121.83M |
June 30, 2021 | 128.40M |
March 31, 2021 | 114.97M |
December 31, 2020 | 99.15M |
September 30, 2020 | 52.63M |
June 30, 2020 | 36.57M |
March 31, 2020 | 32.89M |
December 31, 2019 | 26.62M |
Date | Value |
---|---|
September 30, 2019 | 36.47M |
June 30, 2019 | 27.20M |
March 31, 2019 | 10.64M |
December 31, 2018 | -1.865M |
September 30, 2018 | -21.58M |
June 30, 2018 | -24.67M |
March 31, 2018 | -23.05M |
December 31, 2017 | -33.13M |
September 30, 2017 | -43.96M |
June 30, 2017 | -80.00M |
March 31, 2017 | -103.52M |
December 31, 2016 | -107.59M |
September 30, 2016 | -119.99M |
June 30, 2016 | -108.60M |
March 31, 2016 | -102.40M |
December 31, 2015 | -99.88M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-73.34M
Minimum
Dec 2023
128.40M
Maximum
Jun 2021
42.76M
Average
36.57M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
AtriCure Inc | 4.484M |
NeuroMetrix Inc | -6.085M |
Repligen Corp | 113.92M |
Teleflex Inc | 510.64M |
Perspective Therapeutics Inc | -36.91M |